Associated disorders

The C19orf12 gene has preliminary evidence supporting a correlation with autosomal recessive hereditary spastic paraplegia 43 (MedGen UID: 488575). Other C19orf12-related conditions have been reported (OMIM: 614297).

Order single gene


Order this gene as a single gene test.

Order a test

Invitae tests that include this gene:

C19orf12 is a rare cause of hereditary spastic paraplegia, and the percentage of HSP attributed to pathogenic variants identified in C19orf12 is unknown.

C19orf12 encodes a protein whose function is not well understood, but which localizes to the mitochondria and endoplasmic reticulum in cultured cells.

Assay and technical information

Invitae is a College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified clinical diagnostic laboratory performing full-gene sequencing and deletion/duplication analysis using next-generation sequencing technology (NGS).

Our sequence analysis covers clinically important regions of each gene, including coding exons, +/- 10 base pairs of adjacent intronic sequence, and select noncoding variants. Our assay provides a Q30 quality-adjusted mean coverage depth of 350x (50x minimum, or supplemented with additional analysis). Variants classified as pathogenic or likely pathogenic are confirmed with orthogonal methods, except individual variants that have high quality scores and previously validated in at least ten unrelated samples.

Our analysis detects most intragenic deletions and duplications at single exon resolution. However, in rare situations, single-exon copy number events may not be analyzed due to inherent sequence properties or isolated reduction in data quality. If you are requesting the detection of a specific single-exon copy number variation, please contact Client Services before placing your order.

Gene Transcript reference Sequencing analysis Deletion/Duplication analysis
C19orf12 NM_001031726.3